The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The GCC minimally invasive surgery market exhibited strong growth during 2015-2020. Looking forward, IMARC Group expects the market to continue its strong growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Minimally invasive surgery refers to a surgical technique that involves the use of small tools and cameras. Healthcare providers are increasingly adopting this technique as it allows them to make small, limited incisions in the body. Minimally invasive surgeries employ mini-cameras or endoscopes at the top, allowing the long, slender pipe to move through the incisions. The endoscopic image is then mapped on the monitor, enabling the surgeon to see the surgical region clearly. This procedure is extensively used as it is much safer than conventional open surgeries and reduces hospital stay duration, recovery time, and patient trauma and complication.
The GCC minimally invasive surgery market is primarily driven by the increasing prevalence of cardiac illnesses, arthritis and cancer. Furthermore, the rising geriatric population suffering from chronic diseases is also catalyzing the market growth. Besides this, the high adoption rate of minimally invasive surgeries can be attributed to the increased accuracy and usage of specialized tools that pass through the opening to explore and repair. Additionally, the increasing healthcare spending, outpatient surgery, technological advancements and early recovery are some of the other factors driving the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the GCC minimally invasive surgery market, along with forecasts at the regional and country level from 2021-2026. Our report has categorized the market based on product type, application and end user.
Breakup by Product Type:
Breakup by Application:
Breakup by End User:
Breakup by Country:
The competitive landscape of the industry has also been examined along with the profiles of the key players.
|Base Year of the Analysis||2020|
|Segment Coverage||Product Type, Application, End User, Country|
|Countries Covered||Saudi Arabia, UAE, Qatar, Oman, Kuwait, Bahrain|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 2999
Corporate License: US$ 3999
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
Infantile Spasms Therapeutics Market by Therapeutic Class (Anticonvulsants, Corticosteroids, and Others), Drug Type (Vigabatrin, Adrenocorticotropic Hormone, and Others (Phase III)), Dosage (Solid, Liquid), Route of Administration (Oral, Parenteral, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), End User (Hospitals, Clinics, and Others), and Region 2023-2028
Hyperphosphatemia Drugs Market by Product (Sevelamer, Calcium Based Phosphate Binders, Iron Based Phosphate Binders, Lanthanum Carbonate, and Others), Dosage Form (Tablets, Syrups, Capsules), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
Urology Robotic Surgery Market by Component (Robotic Surgery Systems, Instruments and Accessories, Services), Application (Robotic Prostatectomy, Robotic Cystectomy, Robotic Pyeloplasty, Robotic Nephrectomy, and Others), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at